Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Published on by NESIN Awards

Dr. Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Dirigente Responsabile | Azienda Ospedaliera | Italy

Dr. Giuseppina Peluso is a researcher at the AO of Cosenza in Italy, specializing in reproductive biology with an emphasis on the molecular and cellular mechanisms governing human sperm function. Her work explores the balance between pro-survival and pro-apoptotic pathways, offering deeper insight into the biological foundations of male infertility. Through sustained scientific contributions and broad interdisciplinary collaborations, she advances understanding of how molecular signaling influences sperm quality and reproductive potential. Her research supports the development of innovative therapeutic approaches and contributes to improving clinical strategies in andrology and reproductive health. Peluso’s commitment to evidence-based investigation continues to generate meaningful impact within both scientific and healthcare communities.

Citation Metrics (Scopus)

103
75
50
25
0

Citations

103

Documents

12

h-index

6

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications

Patrice X. Petit | Signal Transduction | Best Researcher Award

Published on by NESIN Awards

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Directors of Department in Hospital| Tongji University | China

Dr. Shaoqing Yu, PhD, is the Director of the Departments of Otorhinolaryngology–Head and Neck Surgery and Allergy at Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. An accomplished clinician-scientist, Dr. Yu specializes in allergy, immunology, and otorhinolaryngology, with a research focus on the mechanisms and clinical management of allergic rhinitis and upper airway inflammation. He has led or participated in more than 20 major research projects, including those funded by the National Natural Science Foundation of China, and has published over 70 peer-reviewed papers in high-impact international journals such as JAMA, Allergy, Clinical and Experimental Allergy, and Clinical Reviews in Allergy & Immunology. His work has substantially advanced understanding of immune regulation and translational therapies in allergic diseases. Dr. Yu is an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and the Chinese Society of Otolaryngology in Traditional Chinese and Western Medicine, fostering global and interdisciplinary collaborations. His achievements have been recognized through numerous awards, including the Third Prize of the Shanghai Medical Technology Award, the Third Prize of the Military Medical Achievement Award, and the Tongji University Taihe Medical Education Award. With over 20 patents to his name and selection for the prestigious Shanghai Oriental Talent Plan, Dr. Yu continues to contribute significantly to medical innovation, education, and the improvement of public health outcomes in China and internationally.

Profiles: Scopus | ORCID 

Featured Publications

Yu, S., et al. (2025). An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: The DUBHE randomized clinical trial. Nature Communications.

Yu, S., et al. (2025). Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis. International Immunopharmacology.

Yu, S., et al. (2025). Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2⁺ CD8⁺ T effector cells. Cell Metabolism.

Yu, S., et al. (2025). Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment. Translational Andrology and Urology.

Yu, S., et al. (2025). Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways. Translational Andrology and Urology.

Dr. Shaoqing Yu’s pioneering research in allergy and immunology has advanced understanding of airway inflammatory diseases and driven the development of innovative diagnostic and therapeutic strategies. His work bridges basic science and clinical application, improving patient outcomes and shaping global standards in allergic disease management.

Ragunath Cholaraj | Biological Sciences | Best Researcher Award

Published on by NESIN Awards

Dr. Ragunath Cholaraj | Biological Sciences | Best Researcher Award

Guest Faculty | Periyar University | India

Dr. Ragunath Cholaraj is a distinguished researcher and academician with extensive expertise in Zoology and Biotechnology, particularly in the field of Aquatic Biotechnology. He holds advanced degrees including dual Master of Science qualifications in Zoology and Biotechnology, an M.Phil., and a Ph.D. from Bharathiar University, where his doctoral research focused on the immunomodulatory effects of fucoidan derived from marine seaweeds on fish immune systems. Professionally, he serves as a Guest Faculty at Periyar University, Salem, and has previously worked as a Research Fellow under the Rashtriya Uchchatar Shiksha Abhiyan (RUSA 2.0) and as a Quality Control Executive at AMEYA Foods (Marico Pvt. Ltd.). His research interests encompass biotechnology, aquaculture, immunology, molecular biology, phytomedicine, cancer biology, nanotechnology, and microbiology. He is proficient in advanced laboratory techniques including molecular diagnostics, nucleic acid analysis, gene expression studies, nanoparticle synthesis, and biochemical assays such as ELISA and Western blotting. As an active journal reviewer for several international journals, he contributes significantly to scholarly peer review. His research accomplishments are reflected in numerous publications in reputed Scopus and SCI-indexed journals, with impactful work on marine bioactive compounds, nanotechnology applications, and immunological studies in aquaculture species. Dr. Ragunath has received several accolades, including the “Young Researcher Award” from the Institute of Scholars and multiple prizes for poster presentations at national and international conferences. His participation in various workshops and faculty development programs highlights his commitment to continuous learning and scientific advancement. Overall, Dr. Ragunath Cholaraj exemplifies a dedicated researcher whose contributions to aquatic biotechnology and interdisciplinary life sciences continue to promote innovation, sustainability, and academic excellence in biological research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Karthik, M., Ragunath, C., Krishnasamy, P., Paulraj, D. Q., & Ramasubramanian, V. (2023). Green synthesis of zinc oxide nanoparticles using Annona muricata leaf extract and its antioxidant and antibacterial activity. Inorganic Chemistry Communications, 157, 111422. Cited by: 27.

  2. Ragunath, C., Kumar, Y. A. S., Kanivalan, I., & Radhakrishnan, S. (2020). Phytochemical screening and GC-MS analysis of bioactive constituents in the methanolic extract of Caulerpa racemosa (Forssk.) J. Agardh and Padina boergesenii Allender & Kraft. Current Applied Science and Technology, 380–393. Cited by: 26.

  3. Cholaraj, R., & Venkatachalam, R. (2024). Investigation of antioxidant and anticancer potential of fucoidan (in-vitro & in-silico) from brown seaweed Padina boergesenii. Algal Research, 79, 103442. Cited by: 18.

  4. Ragunath, C., & Ramasubramanian, V. (2022). Dietary effect of Padina boergesenii on growth, immune response, and disease resistance against Pseudomonas aeruginosa in Cirrhinus mrigala. Applied Biochemistry and Biotechnology, 1(1), 1–12. Cited by: 13.

  5. Ragunath, C., Kousalya, L., Venkatachalam, R., & Anitha, S. (2022). Green synthesis of hydroxyapatite nanoparticles from Wrightia tinctoria and its antibacterial activity. BioNanoScience, 12(3), 723–730. Cited by: 12.

 

Imran Shair Mohammad | Drug Delivery | Best Researcher Award

Published on by NESIN Awards

Dr. Imran Shair Mohammad | Drug Delivery | Best Researcher Award

Postdoctoral Fellow | City of Hope National Medical Center | United States

Dr. Imran Shair Mohammad is a distinguished pharmaceutical scientist whose research focuses on developing next-generation minimally invasive cancer immunotherapies through the design of innovative drug delivery systems and biomaterials. His work lies at the intersection of drug discovery, mRNA and peptide engineering, and biomaterial science, with an emphasis on creating nano/microparticle and hydrogel-based systems for targeted delivery of exosomes, RNA, peptides, and small molecules to improve therapeutic outcomes in cancer, inflammation, and infectious diseases. He earned his Ph.D. in Pharmaceutics from China Pharmaceutical University, Nanjing, following an M.Phil and Pharm.D. from The Islamia University of Bahawalpur, Pakistan. Professionally, Dr. Mohammad has held several postdoctoral research positions across leading international institutions, including the University of North Carolina at Chapel Hill, Erciyes University in Turkey, Sun Yat-sen University in China, and currently serves at the City of Hope National Medical Center, USA. His expertise spans drug and gene delivery, mRNA and peptide synthesis, protein engineering, and immunomodulatory biomaterials, with hands-on proficiency in nanoparticle development, polymer chemistry, and advanced analytical techniques such as HPLC, TEM, and LC-MS. His research interests encompass cancer immunotherapy, drug resistance, cellular engineering, and microbiome-based therapeutics. Dr. Mohammad has published over 40 peer-reviewed articles, received multiple international research grants from the USA, Turkey, and China, and serves on the editorial boards of Cancer Immunology Connect and Current Drug Delivery. Recognized with prestigious honors such as the High-Level Foreign Talents Award from Guangdong Province and the Chinese Government Ph.D. Scholarship, he continues to contribute to advancing translational nanomedicine and targeted immunotherapeutic strategies. His career exemplifies a commitment to scientific innovation, interdisciplinary collaboration, and impactful research that bridges laboratory discoveries with clinical applications for global health advancement.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

1. Mohammad, I. S., He, W., & Yin, L. (2018). Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Biomedicine & Pharmacotherapy, 100, 335–348. https://doi.org/10.1016/j.biopha.2018.02.028 Cited by: 226

2. Mohammad, I. S., Hu, H., Yin, L., & He, W. (2019). Drug nanocrystals: Fabrication methods and promising therapeutic applications. International Journal of Pharmaceutics, 562, 187–202. https://doi.org/10.1016/j.ijpharm.2019.03.055 Cited by: 163

3. Ishaq, H. M., Mohammad, I. S., Guo, H., Shahzad, M., Hou, Y. J., Ma, C., Naseem, Z., … (2017). Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients. Biomedicine & Pharmacotherapy, 95, 865–874. https://doi.org/10.1016/j.biopha.2017.08.097 Cited by: 134

4. Wang, X., Mohammad, I. S., Fan, L., Zhao, Z., Nurunnabi, M., Sallam, M. A., Wu, J., … (2021). Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharmaceutica Sinica B, 11(8), 2585–2604. https://doi.org/10.1016/j.apsb.2021.03.013 Cited by: 130

5. Gu, Y., Mohammad, I. S., & Liu, Z. (2020). Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors. Oncology Letters, 19(4), 2585–2594. https://doi.org/10.3892/ol.2020.11309 Cited by: 120

Somporn Techangamsuwan | Pathology | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Somporn Techangamsuwan | Pathology | Best Researcher Award

Professor | Chulalongkorn University | Thailand

Prof. Dr. Somporn Techangamsuwan (DVM, MSc, PhD, DTBVP) is a distinguished Professor in the Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Thailand. She earned her Doctor of Veterinary Medicine (D.V.M.) from Chulalongkorn University in 1999, followed by a Master of Science in Clinical Pathology from Mahidol University in 2003, and a Ph.D. in Neuroscience from the University of Veterinary Medicine Hannover, Germany, in 2009. She further achieved the Thai Board of Veterinary Pathology (DTBVP) in 2016. Over the course of her academic career, she has progressed from instructor (1999–2009) to professor (since 2018), while also serving in key administrative roles including Assistant Dean of Postgraduate Studies (2016–2021) and Assistant Dean of Research Affairs (2021–present). Her research interests encompass veterinary pathology, infectious diseases, oncology, molecular diagnostics, and clinical pathology, with significant contributions to the understanding of viral infections in companion animals. Her research skills include molecular characterization, virus detection, diagnostic assay development, and neuropathological analysis. Prof. Somporn has an impressive record of scholarly publications, with an H-index of 22 (2021–2025), and has served as an invited editorial board member for Veterinary Pathology and Veterinary Sciences. Her exceptional achievements have earned her numerous awards, including the Outstanding Research Unit Award (2025), multiple Best Presentation and Excellent Research Awards from national and international veterinary congresses, and international recognition from the American Society of Microbiology. Throughout her career, Prof. Somporn has demonstrated excellence in veterinary pathology research and education, significantly advancing diagnostic and molecular veterinary science in Thailand and beyond. Her dedication to academic leadership, innovative research, and mentoring has established her as a leading figure in veterinary pathology and infectious disease research in Southeast Asia.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

  • Pratakpiriya, W., Seki, F., Otsuki, N., Sakai, K., Fukuhara, H., Katamoto, H., … & Techangamsuwan, S. (2012). Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence. Journal of Virology, 86(18), 10207–10210. https://doi.org/10.1128/JVI.01216-12 Citations: 153

  • Lempp, C., Spitzbarth, I., Puff, C., Cana, A., Kegler, K., Techangamsuwan, S., … & Baumgärtner, W. (2014). New aspects of the pathogenesis of canine distemper leukoencephalitis. Viruses, 6(7), 2571–2601. https://doi.org/10.3390/v6072571 Citations: 142

  • Keawcharoen, J., Techangamsuwan, S., Ponpornpisit, A., Lombardini, E. D., Patchimasiri, T., Pirarat, N., … & Oraveerakul, K. (2015). Genetic characterization of a betanodavirus isolated from a clinical disease outbreak in farm‐raised tilapia (Oreochromis niloticus) in Thailand. Journal of Fish Diseases, 38(1), 49–54. https://doi.org/10.1111/jfd.12212 Citations: 75

  • Piewbang, C., Jo, W. K., Puff, C., van der Vries, E., Kesdangsakonwut, S., Rungsipipat, A., & Techangamsuwan, S. (2018). Novel canine circovirus strains from Thailand: Evidence for genetic recombination. Scientific Reports, 8(1), 7524. https://doi.org/10.1038/s41598-018-25882-3 Citations: 72

  • Niwetpathomwat, A., Kaewthamasorn, M., Tiawsirisup, S., Techangamsuwan, S., & Nuchprayoon, S. (2007). A retrospective study of the clinical hematology and the serum biochemistry tests made on canine dirofilariasis cases in an animal hospital population in Bangkok, Thailand. Research in Veterinary Science, 82(3), 364–369. https://doi.org/10.1016/j.rvsc.2006.09.002 Citations: 66

Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Published on by NESIN Awards

Prof. Sergey Suchkov | Clinical Immunology | Excellence in Innovation Award

Professor in Medicine and Immunology | N.D. Zelinskii Institute for Organic Chemistry | Russia

Prof. Sergey V. Suchkov, MD, PhD, is a distinguished physician-scientist and international leader in immunology, personalized and precision medicine, and biodesign. Born in Astrakhan, Russia, he graduated with an MD from Astrakhan State Medical University in 1980 and earned his PhD from Sechenov University in 1985, followed by a Doctor’s Degree from the National Institute of Immunology in 2002. His professional experience spans over four decades, including senior research positions at the USSR Academy of Medical Sciences, the Moscow Clinical Research Institute (MONIKI), and leadership roles as Director of the Center for Personalized & Precision Medicine at Sechenov University, Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University, and Director of the Center for Biodesign at N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences. He has contributed to international collaborations, with advanced training and research engagements at the NEI, NIH, USA, Wills Eye Hospital, Philadelphia, and invited work at several British universities under the Royal Society for Immunology. Prof. Suchkov’s research interests include clinical immunology, predictive and preventive medicine, precision nutrition, and translational biodesign, underpinned by skills in immunobiotechnology, personalized therapy design, clinical trial management, and biomedical innovation. He has authored numerous publications in reputed journals and conferences (IEEE, Scopus-indexed) and actively participates in global professional societies including EPMA, ISPM, PMC, ACS, AHA, ARVO, ISER, and AMEE. Recognized for his leadership and contributions to medical education and clinical practice, he has received multiple honors and holds key advisory roles in international research organizations. Prof. Suchkov’s exceptional expertise, global collaborations, and mentorship capacity position him to advance personalized medicine and immunology research worldwide, foster innovation, and continue contributing to healthcare and scientific communities at the highest level, making him a highly deserving candidate for recognition and awards in his field. 989 Citations | 87 Documents | 12 h-index.

Profiles: Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Suchkov, S. V., Revishvili, A. S., Charchyan, E. R., & Belov, Y. V. (2025). Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional.

  2. Suchkov, S. V., Charchyan, E. R., Polyakova, V. N., & Belov, Y. V. (2025). On the path to personalized cardiology: prospects of precise assessment of cardiovascular risks and predictive-prognostic diagnostics.

  3. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 2. Ecological Comfort as a New and Strategic Factor in the Protection of Modern Human Health.

  4. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Human Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving Systems.

  5. Suchkov, S. V., Abe, H., Murphy, S., & Suvorov, A. N. (2024). Health, Environmental Comfort and Wellbeing through the Integration of Natural and Engineering-Design Bioresources: At the Junction of Pharmaco- and Nutriodesign to the Bioindustry of Tomorrow.

Vishwanath Venketaraman | Infectious Diseases | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Vishwanath Venketaraman | Infectious Diseases | Best Researcher Award

Professor and Discipline Lead for Microbiology and Immunology | Western University of Health Sciences | United States

Prof. Dr. Vishwanath Venketaraman, Ph.D., is a distinguished microbiologist and immunologist with extensive expertise in tuberculosis, HIV, and host-directed therapies. He earned his Ph.D. in Immunology from the National Institute for Research on Tuberculosis (formerly Tuberculosis Research Center) in 1996, following an M.Sc. in Biology (1991) and B.Sc. in Biology (1989) from the University of Madras. He completed postdoctoral research at the University of Ferrara, Italy, and at leading U.S. institutions including the University of Michigan and Rutgers-New Jersey Medical School. Currently, he serves as Full Professor and Discipline Lead for Microbiology and Immunology at the College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, where he teaches immunology, microbiology, and infectious diseases while mentoring students in preclinical and clinical research. His research program focuses on the host immune response against Mycobacterium tuberculosis, HIV co-infections, and type 2 diabetes, aiming to develop novel adjunctive host-directed therapies for tuberculosis. He has led numerous national and international collaborative projects, authored and edited over 164 publications in top journals and books, and serves as editor and reviewer for multiple reputed journals including Intech, Frontiers in Immunology, MDPI, and Springer Nature. Dr. Venketaraman’s professional service includes chairing research committees, mentoring students, serving on NIH and international grant review panels, and active membership in professional societies such as IEEE and ACM. He has received numerous awards including the Provost’s Distinguished Scholar Award, multiple Outstanding Faculty and Distinguished Teacher Awards, Marquis Who’s Who Lifetime Achievement, and recognition for mentoring over 400 students in research leading to publications. His extensive contributions to infectious disease research, education, and global collaboration underscore his leadership and ongoing impact in biomedical science. With an h-index of 32, 145 documents, and over 2,550 citations, Prof. Venketaraman continues to influence the field of microbiology and immunology at the highest level.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Di Virgilio, F., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J. M., & Venketaraman, V. (1998). Cytolytic P2X purinoceptors. Cell Death & Differentiation, 5(3), 191–199. Cited by: 349

  2. Shiehzadegan, S., Alaghemand, N., Fox, M., & Venketaraman, V. (2021). Analysis of the delta variant B.1.617.2 COVID-19. Clinics and Practice, 11(4), 778–784. Cited by: 342

  3. To, K., Cao, R., Yegiazaryan, A., Owens, J., & Venketaraman, V. (2020). General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus. Journal of Clinical Medicine, 9(8), 2541. Cited by: 267

  4. Teskey, G., Abrahem, R., Cao, R., Gyurjian, K., Islamoglu, H., Lucero, M., … & Venketaraman, V. (2018). Glutathione as a marker for human disease. Advances in Clinical Chemistry, 87, 141–159. Cited by: 253

  5. Zhong, W., Shahbaz, O., Teskey, G., Beever, A., Kachour, N., & Venketaraman, V. (2021). Mechanisms of nausea and vomiting: Current knowledge and recent advances in intracellular emetic signaling systems. International Journal of Molecular Sciences, 22(11), 5797. Cited by: 241

Mahnaz Ghaebi | Immunology | Best Researcher Award

Published on by NESIN Awards

Ms. Mahnaz Ghaebi | Immunology | Best Researcher Award

Prospective PhD Student | Zanjan University of Medical Sciences | Iran

Dr. Mahnaz Ghaebi is a medical immunologist and researcher with strong expertise in regenerative medicine, nanotechnology, immunoengineering, biosensors, micro/nanofluidics, and biomaterials. She earned her B.Sc. in Biology from Zanjan University in 2012, graduating as valedictorian and ranked first in her cohort, followed by an M.Sc. in Medical Immunology from Tabriz University of Medical Sciences in 2018, where she completed her thesis on the frequency and epigenetic factors of Treg, Th17, and exhausted T cells in recurrent implantation failure patients. She has enriched her academic training through a Research Internship Course in Pharmaceutical Bioengineering in 2024, covering stem cell design, protein/enzyme engineering, microbial bioengineering, and vaccine design. Professionally, Dr. Ghaebi has served as a Research Assistant at Zanjan University of Medical Sciences (2023–2024), Laboratory Technician during the COVID-19 pandemic, Teaching Assistant guiding students in immunological protocols, and Research Assistant at Tabriz University of Medical Sciences, where she gained hands-on expertise in molecular and cellular biology techniques, flow cytometry, ELISA, and quantitative PCR. Her research interests bridge basic and applied biomedical sciences, with skills extending to bioinformatics, vaccine design, protein modeling, transcriptomic analysis, and computational tools such as R, Python, and Chimera. She has co-authored a book chapter in Springer’s Handbook of Cancer and Immunology and published in reputed journals including Biomedicine & Pharmacotherapy, while also serving as a peer reviewer for international journals such as Survey of Ophthalmology, International Journal of Rheumatic Diseases, and GeroScience. Dr. Ghaebi’s dedication has been recognized with multiple honors, including academic excellence awards, ranking among the top 30 in Iran’s National Entrance Exam for M.Sc., and receiving letters of appreciation for her volunteer leadership during the COVID-19 crisis. Her scholarly contributions reflect growing international recognition, with 1,032 citations by 918 documents, 20 publications, and an h-index of 16.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

  1. Valizadeh, H., Abdolmohammadi-Vahid, S., Danshina, S., Gencer, M. Z., … & Ghaebi, M. (2020). Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. International Immunopharmacology, 89, 107088. Cited by: 306

  2. Ghaebi, M., Nouri, M., Ghasemzadeh, A., Farzadi, L., Jadidi-Niaragh, F., Ahmadi, M., … & Yousefi, M. (2017). Immune regulatory network in successful pregnancy and reproductive failures. Biomedicine & Pharmacotherapy, 88, 61–73. Cited by: 173

  3. Tahmasebi, S., Qasim, M. T., Krivenkova, M. V., Zekiy, A. O., Thangavelu, L., … & Ghaebi, M. (2021). The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients. Cell Biology International, 45(7), 1498–1509. Cited by: 170

  4. Ahmadi, M., Abdolmohammadi-Vahid, S., Ghaebi, M., Aghebati-Maleki, L., Afkham, A., Danaii, S., … & Yousefi, M. (2017). Effect of intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomedicine & Pharmacotherapy, 92, 1095–1102. Cited by: 103

  5. Ghaebi, M., Osali, A., Valizadeh, H., Roshangar, L., & Ahmadi, M. (2020). Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances. Journal of Cellular Physiology, 235(12), 9098–9109. Cited by: 86

Omar Al-Massadi | Metabolism | Best Researcher Award

Published on by NESIN Awards

Dr. Omar Al-Massadi | Metabolism | Best Researcher Award

PhD at IDIS, Spain

Dr. Omar Al-Massadi Iglesias is a distinguished biomedical researcher specializing in neuroendocrinology, obesity, and metabolic diseases. With over two decades of experience in academic research, he has made pivotal contributions to the understanding of energy homeostasis, hypothalamic signaling, and obesity-linked complications like type 2 diabetes. Currently serving as a Principal Investigator under the Miguel Servet program at the Instituto de Investigación Sanitaria de Santiago de Compostela, he leads the “Endocrinología Traslacional” group. His career spans multiple high-impact international collaborations and includes over 66 peer-reviewed publications, many in Q1 journals like Nature Communications, Cell Metabolism, and Diabetes. He is also a reviewer for more than 90 scientific journals and has contributed to both academic and clinical translational research. Dr. Al-Massadi’s work has not only advanced science but also impacted public health policies and treatment strategies, making him a highly influential figure in his field.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Al-Massadi earned a degree in Molecular Biology and Biotechnology from the University of Santiago de Compostela in 2000. He pursued his doctoral studies at the same institution, obtaining a Ph.D. in Physiology in 2010. His doctoral work, which earned him the Extraordinary Doctorate Prize, provided a strong foundation in neuroendocrinology and metabolic regulation. Following this, he enhanced his academic profile through advanced postdoctoral training at top international institutions. Notably, he completed a postdoctoral fellowship at the University of Cincinnati (USA) under the mentorship of Prof. Matthias Tschöp, a globally recognized leader in obesity and diabetes research. He later undertook another postdoctoral position at INSERM-Sorbonne Université in Paris, deepening his expertise in cellular signaling and metabolism. This comprehensive academic journey, combining rigorous theoretical training with international research exposure, has positioned Dr. Al-Massadi as a well-rounded and globally competent scientist.

Experience

Dr. Al-Massadi’s professional experience spans over 20 years in academic and translational research. His career began as a Ph.D. student and early postdoctoral researcher at the University of Santiago de Compostela and the Complejo Hospitalario Universitario de Santiago. He later gained significant international experience in the USA and France, including his pivotal work at the University of Cincinnati and INSERM-Sorbonne Université. Throughout his career, he has participated in 21 competitive research projects, including several as Principal Investigator, and contributed to numerous clinical and preclinical studies. His current role as Principal Investigator in the Miguel Servet program has allowed him to establish his own research group, mentoring graduate students and securing national and regional funding. He has authored over 66 scientific articles, served as a peer reviewer for major journals, and actively contributed to international research networks. His broad experience encompasses molecular biology, endocrinology, neuroscience, and translational medicine.

Research Interest

Dr. Al-Massadi’s primary research interests lie in neuroendocrinology, obesity, and metabolic disease mechanisms. He is particularly focused on understanding the molecular signaling pathways in the hypothalamus that regulate energy homeostasis, appetite, and glucose metabolism. His recent investigations explore the role of Pyk2, a tyrosine kinase, in obesity-induced complications such as type 2 diabetes, aiming to uncover novel therapeutic targets. His translational approach bridges fundamental science with clinical application, particularly in developing innovative treatments for metabolic disorders. He is also interested in mitochondrial dynamics, hormone signaling (e.g., ghrelin and glucagon), and sex-specific metabolic regulation. Through animal models, molecular tools, and human data, Dr. Al-Massadi has made critical contributions to identifying biomarkers and intervention strategies. His passion for interdisciplinary research and commitment to solving real-world health problems make his work both scientifically robust and socially impactful.

Awards and Honors

Dr. Al-Massadi has received numerous accolades recognizing his excellence in scientific research. He was awarded the Extraordinary Doctorate Prize by the University of Santiago de Compostela for his outstanding Ph.D. work. His research contributions have earned him Best Poster and Best Oral Communication awards at national endocrinology and obesity congresses. In 2019, the Spanish Society of Endocrinology and Nutrition honored his work as the Best Published Article of the year. His research has attracted competitive funding through prestigious contracts, including the Miguel Servet, Sara Borrell, and Xunta de Galicia Talent Attraction programs. He has also received international mobility grants and been invited to deliver keynote lectures and scientific talks. In addition, Dr. Al-Massadi holds a European patent (EP24382850.6) for a diagnostic and prognostic method related to obesity. These recognitions highlight not only his scientific talent but also his dedication to translational and impactful biomedical research.

Research Skills

Dr. Al-Massadi possesses an extensive skill set across multiple domains of biomedical research. His core competencies include molecular and cellular biology, animal models of metabolic disease, neuroendocrine regulation, and mitochondrial physiology. He is highly proficient in designing and managing complex experiments involving gene expression analysis, CRISPR/Cas9, immunohistochemistry, and biochemical assays. He has demonstrated expertise in project leadership, securing and managing competitive funding, and supervising doctoral and master’s-level research. His collaborative skills are evidenced by partnerships with global institutions and his active role in multidisciplinary teams. Additionally, he excels in scientific writing, having authored high-impact publications, reviews, and book chapters. As a peer reviewer and scientific committee member, he has evaluated grant proposals and journal articles, showcasing his analytical acumen. His patent development experience reflects innovation, while his communication and mentoring abilities add to his profile as a holistic and forward-thinking researcher.

Publications Top Notes

Title: Central Obestatin and Food Intake Regulation
Authors: CFF Seoane LM, Al-Massadi O, Pazos Y, Pagotto U
Year: 2006
Citation Count: 158

Title: Exercise and Hypothalamic Inflammation
Authors: CX Yi, O Al-Massadi, E Donelan, M Lehti, J Weber, C Ress, C Trivedi, …
Year: 2012
Citation Count: 149

Title: Hypothalamic Ghrelin Pathways and Appetite
Authors: O Al Massadi, M López, M Tschöp, C Diéguez, R Nogueiras
Year: 2017
Citation Count: 148

Title: HDL and Skeletal Muscle Function
Authors: M Lehti, E Donelan, W Abplanalp, O Al-Massadi, KM Habegger, J Weber, …
Year: 2013
Citation Count: 112

Title: MCH and Metabolism Regulation
Authors: M Imbernon, D Beiroa, MJ Vázquez, DA Morgan, C Veyrat–Durebex, …
Year: 2013
Citation Count: 111

Title: Obestatin in Adipocyte Metabolism
Authors: U Gurriarán‐Rodríguez, O Al‐Massadi, A Roca‐Rivada, AB Crujeiras, …
Year: 2011
Citation Count: 103

Title: Ghrelin Acylation and Metabolic Control
Authors: O Al Massadi, MH Tschöp, J Tong
Year: 2011
Citation Count: 96

Title: Ghrelin and Food Reward
Authors: O Al Massadi, R Nogueiras, C Dieguez, JA Girault
Year: 2019
Citation Count: 95

Title: Gastric CB1 Receptor and Ghrelin via mTOR
Authors: LL Senin, O Al-Massadi, C Folgueira, C Castelao, M Pardo, …
Year: 2013
Citation Count: 82

Conclusion

Dr. Omar Al-Massadi Iglesias is an exceptional candidate for the Best Researcher Award, with a track record of excellence in research, innovation, and mentorship. His contributions to the field of obesity and endocrinology are globally recognized, and he has made significant strides in understanding metabolic disorders with clinical implications. His trajectory from international postdoctoral training to becoming an independent research leader, coupled with his prolific publication record and sustained grant success, showcase his future potential as a transformative leader in biomedical research. His work not only advances scientific knowledge but also contributes meaningfully to public health—making him truly deserving of this prestigious recognition.